Symptom relief and side effects of postmenopausal hormones: Results from the postmenopausal estrogen/progestin interventions trial

Obstetrics and Gynecology

Volumn 92, Issue 6, 1998, Pages 982-988

  Greendale, Gail A ^a   Reboussin, Beth A ^b   Hogan, Patricia ^b   Barnabei, Vanessa M ^b   Shumaker, Sally ^b   Johnson, Susan ^b   Barrett Connor, Elizabeth ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; FLUSHING; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EATING DISORDERS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HEADACHE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MEMORY; MIDDLE AGED; MOOD DISORDERS; NEUROBEHAVIORAL MANIFESTATIONS; VASOMOTOR SYSTEM; WEIGHT GAIN;

EID: 0032400929     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00305-6     Document Type: Article

References (30)

1. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 117:1992;1016-1037.
2. Kronenberg F. Hot flashes Phenomenology, quality of life, and search for treatment options . Exp Gerontol. 29:1994;319-336.
3. Hunter M. The South-East England longitudinal study of the climacteric and menopause. Maturitas. 14:1992;117-126.
4. Matthews K.A., Wend P.R., Kuller L.H., Meilahn E.N., Kelsey S.F., Costello E.J., et al. Influences of natural menopause on psychological characteristics and symptoms of middle-aged women. J Consult Clin Psychol. 58:1990;345-351.
5. Kaufert P.A., Gilbert P., Tate R. The Manitoba Project A re-examination of the link between menopause and depression . Maturitas. 14:1992;143-155.
6. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 115:1991;455-456.
7. Walker A.M. Confounding by indication. Epidemiology. 7:1996;335-336.
8. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol. 4:1977;31-47.
9. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 273:1995;199-208.
10. Moos R.H., Leiderman D.B. Toward a menstrual cycle symptom topology. J Psychosom Res. 22:1978;31-40.
11. Muthen B. Contributions to factor analysis of dichotomous variables. Psychometrika. 43:1978;551-560.
12. McCullagh P. Regression models for ordinal data (with discussion). J R Stat Soc Br. 42:1980;109-142.
13. Heagerty P.J., Zeger S.L. Marginal regression models for clustered ordinal measurements. J Am Stat Assoc. 91:1996;1024-1036.
14. Schiff I., Tulchinsky D., Cramer D., Ryan K.J. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA. 244:1980;1443-1445.
15. BeLieu R.M. Mastodynia. Obstet Gynecol Clin North Am. 21:1994;461-477.
16. Sitruk-Ware R., Sterkers N., Mauvais-Jarvis P. Benign breast disease I Hormonal investigation . Obstet Gynecol. 53:1979;457-460.
17. Marsh M.S., Whitcroft S., Whitehead M.I. Paradoxical effects of hormonal replacement therapy on breast tenderness in postmenopausal women. Maturitas. 19:1994;97-102.
18. Studd J., Panay N., Zamblera D., Leather A.T. HRT and long-term compliance The efficacy and safety of Menorest . Int J Gynaecol Obstet. 52:1996;S21-S25.
19. Magos A.L., Brewster E., Singh R., O'Dowd T., Brincat M., Studd J.W.W. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy A model for the premenstrual syndrome . Br J Obstet Gynaecol. 93:1986;1290-1296.
20. Matthews K.A., Meilahn E., Kuller L.H., Kelsey S.F., Caggiula A.W., Wing R.R. Menopause and risk factors for coronary heart disease. N Engl J Med. 321:1989;641-646.
21. Haarbo J., Marslew U., Gotfredsen A., Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 40:1991;1323-1326.
22. Aloia J.F., Vaswani A., Russo L., Sheehan M., Flaster E. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol. 172:1995;896-900.
23. Espeland M.A., Stefanick M.L., Kritz-Silverstein D., Fineberg E., Waclawiw M.A., James M.K., et al. Effect of postmenopausal hormone therapy on body weight and hip girths. J Clin Endocrinol Metab. 82:1997;1549-1556.
24. Barrett-Connor E., Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA. 269:1993;2637-2641.
25. Ditkoff E.C., Cary W.G., Cristo M., Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 78:1991;991-995.
26. Yaffee K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women Effects on cognitive function and dementia . JAMA. 279:1998;688-695.
27. Hunter M.S. Somatic experience of the menopause A prospective study . Psychosom Med. 52:1990;357-367.
28. Holte A. Influences of natural menopause on health complaints A prospective study of healthy Norwegian women . Maturitas. 14:1992;127-141.
29. Lock M., Kaufert P., Gilbert P. Cultural construction of the menopause syndrome The Japanese case . Maturitas. 10:1988;317-322.
30. Welch K.M.A., Darnley D., Simkins R.T. The role of estrogen in migraine A review and hypothesis . Cephalalgia. 4:1984;227-236.